108 filings
Page 5 of 6
8-K
tvj31
2 May 17
Proteon Therapeutics Announces Increase to Enrollment of Ongoing Phase 3 PATENCY-2 Clinical Trial
12:00am
8-K
pacnvz 5kc3bj3
22 Mar 17
Regulation FD Disclosure
12:00am
8-K
mwkl068h
16 Mar 17
Proteon Therapeutics Announces Full-Year 2016 Financial Results and Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial
12:00am
8-K
cul89zkq
13 Dec 16
Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKD
12:00am
8-K
sgdpo9ie051p902t
7 Nov 16
Proteon Therapeutics Announces Third Quarter 2016 Financial Results
12:00am
8-K
yyn4cws9j7lzsis
20 Oct 16
Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors
12:00am
8-K
y040ozv27jsr
8 Aug 16
Proteon Therapeutics Announces Second Quarter 2016 Financial Results
12:00am
8-K
8138t
13 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ldll6
9 May 16
Proteon Therapeutics Announces First Quarter 2016 Financial Results
12:00am
8-K
r6qoe5u 442h
14 Mar 16
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results
12:00am
8-K
w3e3utmnh4p1fj2j83c
22 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
8odp8ulkn 3l
12 Nov 15
Results of Operations and Financial Condition
12:00am
8-K
z04l 8md0takbls5kmd
12 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
vtlbazaanzwj gy6r8i
2 Nov 15
Regulation FD Disclosure
12:00am
8-K
4sl3h6
19 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
27hi768be
13 Aug 15
Regulation FD Disclosure
12:00am
8-K
gd6czkubels j04hv8
13 Aug 15
Results of Operations and Financial Condition
12:00am
8-K
l522n 4ce8dmo35snp0
22 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
mh6v8g3m1geer9q53y
13 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
o1t04 6vn
5 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am